Top 3 factors mapping out prospective opportunities for eubiotics market participants by 2027

Growing number of research programs pertaining to the uses of essential oils for animal health will support the global eubiotics market forecast. As concentrated liquids with plant-derived volatile aromatic compound extracts, essential oil-based eubiotics are garnering considerable attention from the animal husbandry sector as they play a crucial part as digestive stimulants for optimal animal health.

DSM, Friesland Campina, BASF SE, Alltech, and Cargill, Inc. are some top eubiotics manufacturers in the market. These brands have been focusing on product launches and M&As to diversify their market presence.

By 2027, the global eubiotics market size is anticipated to reach about $7 billion.

Eubiotics are deemed as natural digestive stimulants that support animal production. As these products are highly effective in boosting animal productivity in terms of quality and quantity, they are commonly added to animal feed. Essential oils, probiotics, organic acids, and prebiotics are commonly adopted product types across the U.S., Canada, and Australia.

Over the last few years, the use of antibiotics has been decreasing due to availability issues, shortage of novel antibiotic drugs, and increased resistance. Through its Horizon 2020 and One Health Initiative programs, the European Commission (EU) has been focusing on the restriction of indiscriminate usage of antimicrobials for animals. It has highlighted the pressing need for developing alternatives to antibiotics in animal husbandry and veterinary medicine.

The World Health Organization (WHO) and the World Organization for Animal Health (OIE) have also been vocal about the problem. With the routine antibiotic usage becoming unacceptable following the ban on metaphylactic/ prophylactic antibiotic use in livestock from 2022 onward, Europe eubiotics market share is increasing at a significant CAGR. Industry participants are engaged in addressing the gap left by antibiotics. They are developing effective and scientifically proven alternatives to conventional antibiotic drugs.

Derived from the Greek terms ‘eu’ that roughly translates to ‘healthy’ and ‘bios’, that refers to ‘life’, eubiosis can be defined as the science of healthy living by maintaining a healthy gut. North American animal health industry is emphasizing growth and maintenance of gut health as well as immunity during the calf stage, with a view to ensure optimal production as adult animals.

As such, by application, the eubiotics industry share from the gut health segment is likely to register a promising revenue through 2027. Since these products aid in the management of micro-flora in the gastrointestinal tract, farm animals are benefitting from improved health status. Product consumption has several advantages, such as:

Although the demand across the poultry industry slackened for a short time during the COVID-19 pandemic, from 2022, chicken and egg consumption is expected to rise considerably across the countries in Asia Pacific. China eubiotics industry size is expanding, thanks to the increased investments toward a sustainable livestock sector.

Regional government has been seeking for ways to accelerate domestic production to cater to the ever-rising meat demand across Chinese provinces. According to a 2020 report published by the USDA, China ranked third largest chicken meat importer from the U.S., during the first five months of 2020. Restaurants across India, Malaysia, and Australia are witnessing a spiraling demand for chicken-based savories, impacting the industry forecast.